Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
Diabetes research and clinical practice. 2024 Mar ; 209:111589
Burden of cardiometabolic risk factors and vascular health
American heart journal. 2024 Mar ; 269:201-204
Circ_ST6GAL1-mediated competing endogenous RNA network regulates TGF-β1-stimulated matrix Metalloproteinase-13 expression via Runx2 acetylation in osteoblasts
Non-coding RNA research. 2024 Mar ; 9:153-164
Inclusion of Sex and Gender Differences in U.S. State Action Plans for Opioid Use and Opioid Use Disorder
Journal of women's health (Larchmont, N.Y. : 2002). 2024 Mar ; 33:275-282
The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease
Cardiovascular research. 2024 Feb 17; 119:2813-2824
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities
Cardiovascular research. 2024 Feb 17; 119:2771-2773
Continuous glucose monitoring captures glycemic variability in obesity after sleeve gastrectomy: A prospective cohort study
Obesity science & practice. 2024 Feb 01; 10:?-?
Recipients of the 2024 Early Career Investigator Awards
Arteriosclerosis, thrombosis, & vascular biology. 2024 Feb 01;